They're in Switzerland and Germany.
Two more manufacturing sites have been approved by European health regulators for the BioNtech/Pfizer Covid vaccine.
The sites in Germany and Switzerland are expected to support the continued supply of the vaccine in the European Union.
According to the EMA, the sites can become operational immediately.
EMA has approved additional manufacturing sites for the production of Comirnaty, the #COVID19vaccine developed by BioNTech and Pfizer. https://t.co/kFXSVB6rRn#VaccinesWork #CovidVaccines pic.twitter.com/sKSBaBkrzu
— EU Medicines Agency (@EMA_News) June 22, 2021

Microsoft Outage Causing Global Disruption To Services
One Killed And Four Injured In Washington DC Shooting
Nvidia Boss Resigns After Reports Of Two Affairs, One Allegedly With A Chinese Spy
Ukraine And Russia Agree Large-Scale Exchange Of Prisoners Following Talks
Russell Brand Sentenced To 10.5 Years In Prison For Rape, Sexual Assault
French Prime Minister Claims Aer Lingus Pilots Initially Refused To Land In France After Bomb Threat
Russell Brand Found Guilty of Rape and Three Counts of Sexual Assault
US Vice President Blames Iran War For Republican Collapse